4//SEC Filing
VAGELOS P ROY 4
Accession 0001883850-22-000121
CIK 0000872589other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:12 PM ET
Size
12.7 KB
Accession
0001883850-22-000121
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Gift
Common Stock
2022-07-05−357→ 126,347 total(indirect: by CLAT) - Gift
Common Stock
2022-10-03−304→ 126,043 total(indirect: by CLAT) - Tax Payment
Common Stock
2022-12-09$753.28/sh−57$42,937→ 322,432 total - Gift
Common Stock
2022-05-24−23,077→ 322,489 total - Gift
Common Stock
2022-04-06−302→ 126,704 total(indirect: by CLAT)
Holdings
- 2,102(indirect: By 401(k))
Common Stock
- 23,461(indirect: By Trust)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
IncorporatedMD
Related Parties
1- filerCIK 0001013064
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:12 PM ET
- Size
- 12.7 KB